Resorbable Magnesium Scaffolds Registry

Last updated: May 16, 2023
Sponsor: Biotronik AG
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hypercholesterolemia

Thrombosis

Heart Disease

Treatment

Magmaris

Clinical Study ID

NCT04679740
C1908
  • Ages > 18
  • All Genders

Study Summary

The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • According to the IFU

Exclusion

Exclusion Criteria:

  • According to the IFU

Study Design

Total Participants: 1106
Treatment Group(s): 1
Primary Treatment: Magmaris
Phase:
Study Start date:
November 18, 2020
Estimated Completion Date:
December 01, 2026

Connect with a study center

  • Heart Center Segeberger Kliniken

    Bad Segeberg, 23795
    Germany

    Active - Recruiting

  • Herz-und Gefäßzentrum Oberallgäu-Kempten

    Kempten,
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.